{"TopicDetails": {"type": 0, "ccm2Id": 44320963, "cftId": 0, "identifier": "EU4H-2021-PJ-11", "title": "Action grants for \u2018EU Cancer Treatment Capacity and Capability Mapping\u2019 project - Network of Comprehensive Cancer Centres", "publicationDateLong": 1634083200000, "callIdentifier": "EU4H-2021-PJ2", "callTitle": "Project grants wave 2", "callccm2Id": 44321039, "allowPartnerSearch": true, "workProgrammepart": {"id": 5874, "ccm_id": 44188220, "wp_part": "EU4H-2021", "wp_year": "EU4H-2021", "wp_title": "EU4H-2021", "wp_website": "https://ec.europa.eu/health/", "wp_document": "https://ec.europa.eu/health/funding/eu4health_en"}, "frameworkProgramme": {"id": 43332642, "abbreviation": "EU4H", "description": "EU4 Health Programme (EU4H)"}, "programmeDivision": [{"id": 43332657, "abbreviation": "Health", "description": "Improving and fostering health in the Union to reduce the burden of communicable and non-communicable diseases"}, {"id": 43332653, "abbreviation": "EU4H-1", "description": "EU4H-1"}], "topicMGAs": [], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "EU4H-PJG EU4H Project Grants", "typeOfMGA": [{"id": 43326018, "abbreviation": "EU4H-AG", "description": "EU4H Action Grant Budget-Based"}]}], "plannedOpeningDate": "14 October 2021", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["25 January 2022"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3382142": [{"action": "EU4H-2021-PJ-12 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "14 October 2021", "deadlineModel": "single-stage", "deadlineDates": ["25 January 2022"], "budgetYearMap": {"2021": 1800000}, "budgetTopicActionMap": {}}], "3382144": [{"action": "EU4H-2021-PJ-15 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "14 October 2021", "deadlineModel": "single-stage", "deadlineDates": ["25 January 2022"], "budgetYearMap": {"2021": 6000000}, "budgetTopicActionMap": {}}], "3382146": [{"action": "EU4H-2021-PJ-14 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "14 October 2021", "deadlineModel": "single-stage", "deadlineDates": ["25 January 2022"], "budgetYearMap": {"2021": 7000000}, "budgetTopicActionMap": {}}], "3382148": [{"action": "EU4H-2021-PJ-18 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "14 October 2021", "deadlineModel": "single-stage", "deadlineDates": ["25 January 2022"], "budgetYearMap": {"2021": 2500000}, "budgetTopicActionMap": {}}], "3382150": [{"action": "EU4H-2021-PJ-13 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "14 October 2021", "deadlineModel": "single-stage", "deadlineDates": ["25 January 2022"], "budgetYearMap": {"2021": 5000000}, "budgetTopicActionMap": {}}], "3382152": [{"action": "EU4H-2021-PJ-09 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "14 October 2021", "deadlineModel": "single-stage", "deadlineDates": ["25 January 2022"], "budgetYearMap": {"2021": 4400000}, "budgetTopicActionMap": {}}], "3382154": [{"action": "EU4H-2021-PJ-17 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "14 October 2021", "deadlineModel": "single-stage", "deadlineDates": ["25 January 2022"], "budgetYearMap": {"2021": 4000000}, "budgetTopicActionMap": {}}], "3382156": [{"action": "EU4H-2021-PJ-08 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "14 October 2021", "deadlineModel": "single-stage", "deadlineDates": ["25 January 2022"], "budgetYearMap": {"2021": 1200000}, "budgetTopicActionMap": {}}], "3382158": [{"action": "EU4H-2021-PJ-11 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "14 October 2021", "deadlineModel": "single-stage", "deadlineDates": ["25 January 2022"], "budgetYearMap": {"2021": 1200000}, "budgetTopicActionMap": {}}], "3382160": [{"action": "EU4H-2021-PJ-10 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "14 October 2021", "deadlineModel": "single-stage", "deadlineDates": ["25 January 2022"], "budgetYearMap": {"2021": 2000000}, "budgetTopicActionMap": {}}], "3382162": [{"action": "EU4H-2021-PJ-16 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "14 October 2021", "deadlineModel": "single-stage", "deadlineDates": ["25 January 2022"], "budgetYearMap": {"2021": 3000000}, "budgetTopicActionMap": {}}], "3382164": [{"action": "EU4H-2021-PJ-06 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "14 October 2021", "deadlineModel": "single-stage", "deadlineDates": ["25 January 2022"], "budgetYearMap": {"2021": 5000000}, "budgetTopicActionMap": {}}], "3382166": [{"action": "EU4H-2021-PJ-07 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "14 October 2021", "deadlineModel": "single-stage", "deadlineDates": ["25 January 2022"], "budgetYearMap": {"2021": 750000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2021"]}, "description": "<SPAN class=\"topicdescriptionkind\">ExpectedOutcome</SPAN>:<p><strong>POLICY CONTEXT</strong></p><p>The European Guide on Quality Improvement in Comprehensive Cancer Control recommends as a priority the establishment of Comprehensive Cancer Care Networks, and likewise the Horizon Europe Cancer Mission Board recommends the establishment of such structures in all Member States as well as the networking of these centres at Union level.</p><p>One of the flagship initiatives of Europe\u2019s Beating Cancer Plan is the establishment by 2025 of an EU Network linking recognised National Comprehensive Cancer Centres in every Member State to facilitate the uptake of quality-assured diagnosis and treatment, in agreement with the European guidelines and quality assurance schemes for population based screening programmes, including training, research and clinical trials across the Union. The Cancer Plan aims to ensure that 90% of eligible patients have access to such centres by 2030.</p><p><span><span>This action supports the implementation of a flagship initiative of Europe\u2019s Beating Cancer Plan objective to deliver higher-quality care and links also with the European Health Data Space and the European Digital Cancer Patient Centre, and implements the EU4HealthProgramme\u2019s general objective of improving and fostering health in the Union (Article 3, point (a)) through the specific objectives defined in Article 4, points (a) and (g) of Regulation (EU) 2021/522.</span></span></p>\n<SPAN class=\"topicdescriptionkind\">Objective</SPAN>:<p><strong>OBJECTIVES</strong><br><span>The \u2018EU Cancer Treatment Capacity and Capability Mapping\u2019 action aims to map and share the different capabilities and expertise available across the Union.</span></p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p><strong><span>DESCRIPTION OF THE ACTIVITIES TO BE FUNDED UNDER THIS TOPIC </span></strong><br><span>The action will support the identification of the different capabilities and expertise available across the Union, and build the foundation to regularly identify gaps and needs to be addressed at national and regional level across the Union. At the same time, the EU Network of Comprehensive Cancer Centres will be updated on cancer care innovation as well as on cancer workforce training.</span></p>\n<SPAN class=\"topicdescriptionkind\">Expected Impact</SPAN>:<p><strong>EXPECTED RESULTS AND IMPACT</strong><br><span>The mapping of EU Cancer Treatment Capacity and Capability in the Member States is expected to result in facilitating the delivery of higher-quality care and reduce inequalities across the Union, while enabling patients to benefit from diagnosis and treatment close to home.</span></p><p><strong><span>SPECIFIC ACTION-LEVEL INDICATORS FOR REPORTING PURPOSES </span></strong></p><p>Applicants must include data on the following indicators in their regular reporting activities in case of award, and must be prepared to include additional specific indicators where needed:</p><ul level=\"0\"><li><span>Number of inputs treated by the scanning exercise. </span></li><li><span>Number (including types) of regular reports provided by the horizon scanning tool(s) developed and operated by the project. </span></li><li><span>Number (including types) of downloads of reports.</span></li> </ul><p><span><span>Number (including types) of topics identified, selected and prioritised to be included and followed up by the activities implemented in the context of the Comprehensive Cancer Infrastructures.</span></span></p>\n", "conditions": "<p><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\">Conditions<br />\r\n<br type=\"_moz\" />\r\n</span></b></p>\r\n<p><b><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:&#10;text1;mso-themetint:191;mso-ansi-language:EN-US\">1.&nbsp;</span></b><b><span lang=\"EN-US\">Admissibility conditions: </span></b><span lang=\"EN-US\">described in section 5 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2021/call-fiche_eu4h-2021-pj-02_en.pdf\" target=\"_blank\">call document.</a>&nbsp;</span></p>\n<p><b><span lang=\"EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\">&nbsp;described in section 5 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2021/call-fiche_eu4h-2021-pj-02_en.pdf\" target=\"_blank\">call document</a></span></p>\n<p><b><span lang=\"EN-US\">2. Eligible countries:&nbsp;</span></b><span lang=\"EN-US\">described in section 6 of of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2021/call-fiche_eu4h-2021-pj-02_en.pdf\" target=\"_blank\">call document</a></span></p>\n<p><b><span lang=\"EN-US\">3. Other eligibility conditions:</span></b><span lang=\"EN-US\">&nbsp;described in section 6 of the <a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/temp-form/af/detailed-budget-table_eu4h_en.xlsm\" target=\"_blank\">call document</a></span></p>\n<p><b>4. Financial and operational capacity and exclusion:&nbsp;</b>described in&nbsp;<span lang=\"EN-US\">section 7 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2021/call-fiche_eu4h-2021-pj-02_en.pdf\" target=\"_blank\">call document</a></span></p>\n<p><b><span lang=\"FR-BE\">5.&nbsp;Evaluation and award:</span></b></p>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Award criteria, scoring and thresholds:</span></b><span lang=\"EN-US\">&nbsp;described in section 9 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2021/call-fiche_eu4h-2021-pj-02_en.pdf\" target=\"_blank\">call document</a></span></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">Submission and evaluation processes</span></b><b><span lang=\"EN-US\">:</span></b><span lang=\"EN-US\">&nbsp;described&nbsp;<span style=\"color: rgb(64, 64, 64);\">section 8 of the call document and the</span>&nbsp;</span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span lang=\"EN-US\">Online Manual</span></a></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Indicative timeline for evaluation and grant agreement:&nbsp;</span></b><span lang=\"EN-US\">described in section 4 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2021/call-fiche_eu4h-2021-pj-02_en.pdf\" target=\"_blank\">call document</a></span></li>\r\n</ul>\n<p><b><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">6</span></b><b><span lang=\"EN-US\">. Legal and financial set-up of the grants:&nbsp;</span></b><span lang=\"EN-US\">described&nbsp;<span style=\"color: rgb(64, 64, 64);\">in section 10 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2021/call-fiche_eu4h-2021-pj-02_en.pdf\" target=\"_blank\">call document</a></span></span></p>\r\n<p>&nbsp;</p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\">Documents<br />\r\n<br />\r\n<o:p></o:p></span></b><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\"><b><span lang=\"EN-US\">Call documents:</span></b></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\"><span style=\"color: rgb(51, 51, 51); font-family: eui-default, Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 14px;\">Text of the EU4HEALTH Call document:&nbsp;</span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2021/call-fiche_eu4h-2021-pj-02_en.pdf\" target=\"_blank\">Call document </a><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; line-height: 1.618; font-family: eui-default, Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 14px; margin: 1rem 0px; padding: 0px; color: rgb(51, 51, 51);\"><span lang=\"EN-US\" style=\"box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; margin: 0px; padding: 0px;\">EU4health standard application form:&nbsp;<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/temp-form/af/af_eu4h_en.pdf\" target=\"_blank\">Standard application form</a>&nbsp;&nbsp;</span></p>\r\n<p class=\"MsoNormal\" style=\"box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; line-height: 1.618; font-family: eui-default, Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 14px; margin: 1rem 0px; padding: 0px; color: rgb(51, 51, 51);\"><span lang=\"EN-US\" style=\"box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; margin: 0px; padding: 0px;\">EU4Health detailed budget:&nbsp;<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/how-to-participate/reference-documents;programCode=EU4H\" target=\"_blank\">EU4Health Detailed budget table</a>&nbsp;</span></p>\r\n<p class=\"MsoNormal\" style=\"box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; line-height: 1.618; font-family: eui-default, Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 14px; margin: 1rem 0px; padding: 0px; color: rgb(51, 51, 51);\"><span style=\"box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; margin: 0px; padding: 0px;\">EU4Health Programme:&nbsp;<a href=\"https://ec.europa.eu/health/funding/eu4health_en\" target=\"_blank\">EU4Health programme</a>&nbsp;</span></p>\n<p><span lang=\"EN-US\" style=\"line-height: 15.3333px; color: rgb(64, 64, 64);\">EU4Health:</span><span lang=\"EN-US\" style=\"font-size: 10pt; line-height: 15.3333px; font-family: &quot;Segoe UI&quot;, sans-serif; color: rgb(64, 64, 64);\">&nbsp;</span><span class=\"MsoHyperlink\"><span style=\"color: rgb(64, 64, 64);\">&nbsp;<a href=\"https://ec.europa.eu/health/funding/eu4health_en\" target=\"_blank\">2021 Annual Work Programme</a></span></span></p>\r\n<p><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">EU4Health Regulation:&nbsp;</span><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">&nbsp;<a href=\"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.L_.2021.107.01.0001.01.ENG\" target=\"_blank\">Regulation 2021/522</a></span></p>\r\n<p>EU financial Regulation:&nbsp;<a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\"><span lang=\"EN-US\">EU Financial Regulation 2018/1046</span></a></p>", "supportInfo": "<p><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">For help related to this</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">&nbsp;</span><b style=\"font-family: Arial, sans-serif; font-size: 9pt;\">call</b><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">, please contact:</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">&nbsp;</span>HaDEA-HP-CALLS@ec.europa.eu</p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;grantAndTendertype=1;categories=p_submission_eval;programme=null;actions=;keyword=;period=null\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Funding &amp; Tenders Portal FAQ</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Submission of proposals.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">IT Helpdesk</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Contact the IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Online+Manual\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Online Manual</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Step-by-step online guide through the Portal processes from proposal preparation and submission to reporting on your on-going project. Valid for all 2021-2027 programmes.</span></p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"additionalInfo": "<p>&nbsp;On 24 March 2021, the EU4Health Regulation was adopted as part of the EU Multiannual Financial Framework for the 2021-2027 period. The EU4Health Regulation established &lsquo;the EU4Health Programme&rsquo;. This marks an important step towards making available instruments and solutions to support Member States in building stronger, more resilient and accessible health systems.</p>\r\n<p>The EU4Health Programme represents an unprecedented level of financial commitment for the EU in health in comparison with previous health programmes. The Programme is EU&rsquo;s response to the current public health emergency that will make a significant contribution to the post-COVID-19 recovery aiming to:<br />\r\n- improve public health in the Union through disease prevention and health promotion, as well as international health initiatives and cooperation;<br />\r\n- protect people from serious cross-border health threats through prevention, preparedness and response to cross-border health threats; complementing national stockpiling of essential crisis-relevant products; and establishing a reserve of medical, healthcare and support staff;<br />\r\n- improve access to medicinal products, medical devices and crisis-relevant products by encouraging sustainable production and supply chains and innovation in the Union and efficient use of medicinal products;<br />\r\n- strengthen the national health systems through improved health data use and re-use, development of digital tools and services, digital transformation of healthcare; enhancing access to healthcare; developing and implementing EU health legislation and evidence-based decision making; and integrated work among Member States&rsquo; health systems.</p>\r\n<p>Cancer is the second leading cause of mortality in the Member States after cardiovascular disease. The prevention and control of cancer would benefit the majority of citizens since it shares common risk factors with other non-communicable diseases. Europe&rsquo;s Beating Cancer Plan, which is a key pillar of a stronger European Health Union, tackles the entire cancer disease pathway by means of flagship initiatives, such as launching a Cancer Inequalities Registry, and supporting actions, such as establishing an EU Network of Youth Cancer Survivors. The EU4Health programme will provide the financial support to implement these initiatives that are important to mitigate the impact of the COVID-19 pandemic on cancer control and care.</p>\r\n<p>Grants shall involve co-financing. Grants paid by the Union shall not exceed 60 % of eligible costs for an action relating to an objective of the Programme. In cases of exceptional utility, the contribution by the Union may be up to 80 % of eligible costs.</p>\r\n<p>&nbsp;</p>", "staticAdditionalInfo": "", "latestInfos": [{"approvalDate": "Oct 26, 2022 11:38:58 AM", "lastChangeDate": "Oct 26, 2022 11:38:58 AM", "content": "<p class=\"MsoNormal\"><span style=\"font-size:10.5pt;line-height:115%;font-family:&#10;&quot;inherit&quot;,serif;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-bidi-font-family:&#10;Arial;color:#333333;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;&#10;padding:0cm;mso-ansi-language:EN-IE;mso-fareast-language:EN-IE\">A total of 55 </span><b><span style=\"font-size:10.5pt;line-height:115%;font-family:&quot;inherit&quot;,serif;&#10;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-bidi-font-family:Helvetica;&#10;color:#333333;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0cm;&#10;padding:0cm;mso-ansi-language:EN-IE;mso-fareast-language:EN-IE\">proposals have been submitted&nbsp;</span></b><span style=\"font-size:10.5pt;line-height:115%;&#10;font-family:&quot;inherit&quot;,serif;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;mso-bidi-font-family:Arial;color:#333333;border:none windowtext 1.0pt;&#10;mso-border-alt:none windowtext 0cm;padding:0cm;mso-ansi-language:EN-IE;&#10;mso-fareast-language:EN-IE\">in response to this call.</span><span lang=\"EN-GB\"><o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2021-PJ-06: 1 proposal<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2021-PJ-07: 2 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2021-PJ-08: 2 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2021-PJ-09: 11 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2021-PJ-10: 2 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2021-PJ-11: 1 proposal<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2021-PJ-12: 2 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2021-PJ-13: 12 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2021-PJ-14: 5 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2021-PJ-15: 6 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2021-PJ-16: 3 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span lang=\"FR\" style=\"font-family:&#10;Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:&#10;FR\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang=\"FR\" style=\"mso-ansi-language:FR\">EU4H-2021-PJ-17: 3 proposals<o:p></o:p></span></p>\r\n<p class=\"MsoListParagraph\" style=\"margin-left:36.0pt;text-indent:-18.0pt;&#10;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style=\"font-family:Symbol;&#10;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol\"><span style=\"mso-list:Ignore\">&middot;<span style=\"font:7.0pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]-->EU4H-2021-PJ-18: 5 proposals<o:p></o:p></p>"}, {"approvalDate": "Oct 14, 2021 12:00:00 AM", "lastChangeDate": "Oct 14, 2021 12:00:00 AM", "content": "The submission session is now available for: EU4H-2021-PJ-06(EU4H-PJG), EU4H-2021-PJ-08(EU4H-PJG), EU4H-2021-PJ-07(EU4H-PJG), EU4H-2021-PJ-16(EU4H-PJG), EU4H-2021-PJ-10(EU4H-PJG), EU4H-2021-PJ-15(EU4H-PJG), EU4H-2021-PJ-09(EU4H-PJG), EU4H-2021-PJ-12(EU4H-PJG), EU4H-2021-PJ-11(EU4H-PJG), EU4H-2021-PJ-14(EU4H-PJG), EU4H-2021-PJ-13(EU4H-PJG), EU4H-2021-PJ-18(EU4H-PJG), EU4H-2021-PJ-17(EU4H-PJG)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}